Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) December weekly option implied volatility is at 55, December is at 51; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Autodesk (ADSK) call put ratio 1.4 calls to 1 puts into quarter results
• GAP (GAP) call put ratio 3.5 calls to 1 put into quarter results
• Blackstone (BX) 26500 contracts of November 155 puts trade